enVVeno Medical (NVNO) Debt Ratio (2017 - 2020)

enVVeno Medical's quarterly Debt Ratio came in at 0.08 in Q2 2020, up 4.35% quarter-over-quarter from 0.07 in Q1 2020.

enVVeno Medical has reported Debt Ratio for 2 years, with the latest figure at 0.08 in Q2 2020.

  • For the quarter ending Q2 2020, Debt Ratio changed N/A year-over-year to 0.08; the trailing twelve-month figure through Jun 2020 stood at 0.08 (changed N/A YoY), and the FY2017 full-year result was 1.39, changed N/A from the prior year.
  • Debt Ratio for Q2 2020 stood at 0.08, up from 0.07 in the prior quarter.
  • The five-year high for Debt Ratio was 1.39 in Q4 2017, with the low at 0.07 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 enVVeno Medical 6.99 Mn 6.99 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 0.08
Mar 31, 2020 0.07
Dec 31, 2017 1.39